Turning stats into outcomes
April 23, 2013
The annual biotechnology report from Ernst & Young claims that the major players continue to perform well but claims that in a challenging environment, the rest of the sector needs to up its game in demonstrating value
April 03, 2012
Leaner times may be over for investigative sites conducting clinical research around the world, a new CenterWatch study indicates.
February 01, 2012
Roche’s 2011 earnings may have experienced a 4% drop but the company is remaining optimistic about growth in the new year as new products flood onto the market.
August 11, 2011
German drugmaker Stada has posted healthy increases in revenues and profits in the first half of 2011 on the back of increased international sales and the expansion of its branded products business.
PharmaTimes 2013 Copyright | RSS Feed Subscriptions